Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immune checkpoint inhibitors
Page 1 of 1 ( 50 items )
<<
1
>>
1
Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review
7/9/2025 7:00:43 AM |
Browse: 19 |
Download: 86
2
Early identification and multidisciplinary management of immune checkpoint inhibitors associated colitis can improve patient outcomes
12/27/2024 1:37:13 PM |
Browse: 72 |
Download: 346
3
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM |
Browse: 114 |
Download: 519
4
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
9/19/2024 12:00:22 PM |
Browse: 90 |
Download: 383
5
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
9/18/2024 11:53:42 AM |
Browse: 82 |
Download: 354
6
Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
2/15/2023 12:44:08 AM |
Browse: 308 |
Download: 1222
7
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
10/18/2022 8:29:59 AM |
Browse: 378 |
Download: 1153
8
Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report
9/29/2022 9:17:29 AM |
Browse: 400 |
Download: 1298
9
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 521 |
Download: 1421
10
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
7/27/2022 1:17:37 PM |
Browse: 633 |
Download: 1302
11
Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
7/22/2022 9:38:18 AM |
Browse: 504 |
Download: 1276
12
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM |
Browse: 545 |
Download: 1307
13
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM |
Browse: 548 |
Download: 1171
14
Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
5/25/2022 8:33:35 AM |
Browse: 451 |
Download: 1082
15
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
5/24/2022 12:41:49 PM |
Browse: 466 |
Download: 935
16
Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
5/24/2022 12:41:49 PM |
Browse: 458 |
Download: 1298
17
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM |
Browse: 473 |
Download: 1196
18
Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
4/21/2022 11:35:30 AM |
Browse: 349 |
Download: 884
19
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
2/23/2022 3:51:55 PM |
Browse: 499 |
Download: 1591
20
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
2/11/2022 5:55:20 AM |
Browse: 446 |
Download: 1365
21
Update on the treatment of metastatic renal cell carcinoma
1/22/2022 6:17:12 AM |
Browse: 495 |
Download: 971
22
Targets of immunotherapy for hepatocellular carcinoma: An update
1/21/2022 8:16:14 AM |
Browse: 483 |
Download: 1014
23
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
1/11/2022 12:11:23 AM |
Browse: 499 |
Download: 1371
24
New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies
12/24/2021 9:48:20 AM |
Browse: 467 |
Download: 1059
25
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
12/17/2021 8:56:01 AM |
Browse: 572 |
Download: 1295
26
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
11/6/2021 4:43:07 AM |
Browse: 630 |
Download: 1437
27
Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
10/21/2021 8:44:04 AM |
Browse: 507 |
Download: 1107
28
Immune checkpoint inhibitor-related hepatotoxicity: A review
8/25/2021 2:11:51 AM |
Browse: 641 |
Download: 1421
29
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
8/14/2021 11:08:13 AM |
Browse: 669 |
Download: 1103
30
Current cancer therapies and their influence on glucose control
7/12/2021 5:45:28 AM |
Browse: 571 |
Download: 1394
31
Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature
5/26/2021 9:58:02 AM |
Browse: 554 |
Download: 1385
32
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
5/14/2021 9:21:56 AM |
Browse: 576 |
Download: 1668
33
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
1/7/2021 10:14:28 AM |
Browse: 589 |
Download: 1133
34
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
12/18/2020 12:27:09 PM |
Browse: 655 |
Download: 1463
35
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
11/26/2020 8:54:27 AM |
Browse: 752 |
Download: 1501
36
Deep diving in the PACIFIC: Practical issues in stage III non-small-cell lung cancer to avoid shipwreck
11/18/2020 2:20:37 PM |
Browse: 864 |
Download: 1518
37
Steroid-responsive pancreatitides
8/25/2020 9:45:46 AM |
Browse: 746 |
Download: 1733
38
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM |
Browse: 1000 |
Download: 2075
39
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM |
Browse: 1051 |
Download: 1761
40
Antibiotics and immunotherapy in gastrointestinal tumors: friend or foe?
6/6/2019 5:44:00 PM |
Browse: 1015 |
Download: 1908
41
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
5/28/2019 9:29:42 AM |
Browse: 1035 |
Download: 2006
42
Immune checkpoint inhibitor-induced colitis: A comprehensive review
2/26/2019 9:05:11 AM |
Browse: 905 |
Download: 1626
43
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
9/20/2018 2:33:54 AM |
Browse: 1013 |
Download: 1811
44
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
8/27/2018 7:22:43 AM |
Browse: 1177 |
Download: 1669
45
Immunotherapies in sarcoma: Updates and future perspectives
4/7/2017 8:24:12 AM |
Browse: 1132 |
Download: 1626
46
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
2/27/2017 6:19:00 PM |
Browse: 1095 |
Download: 1615
47
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM |
Browse: 1125 |
Download: 1716
48
Immune checkpoint therapy for pancreatic cancer
11/18/2016 3:13:00 PM |
Browse: 1175 |
Download: 1604
49
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?
8/10/2016 3:41:00 PM |
Browse: 1337 |
Download: 1941
50
Potentiality of immunotherapy against hepatocellular carcinoma
9/28/2015 11:46:00 AM |
Browse: 1141 |
Download: 2047
Page 1 of 1 ( 50 items )
<<
1
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345